Evidence map›Paper›PMID 41509642›Full record

ArticleRSC medicinal chemistry2026

Eunsil Kim, Ji Young Hyun, Ji Ho Song, Hwan Jung Lim, Seong Jun Park

Abstract read
In one paragraph

Article in RSC medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eunsil KimDepartment of Drug Discovery, Korea Research Institute of Chemical Technology (KRICT) 141 Gajeong-ro, Yuseong-gu Daejeon 34114 Republic of Korea sjunpark@krict.re.kr +82 42 860 7160 +82 42 860 7175.
Ji Young HyunDepartment of Drug Discovery, Korea Research Institute of Chemical Technology (KRICT) 141 Gajeong-ro, Yuseong-gu Daejeon 34114 Republic of Korea sjunpark@krict.re.kr +82 42 860 7160 +82 42 860 7175.
Ji Ho SongDepartment of Drug Discovery, Korea Research Institute of Chemical Technology (KRICT) 141 Gajeong-ro, Yuseong-gu Daejeon 34114 Republic of Korea sjunpark@krict.re.kr +82 42 860 7160 +82 42 860 7175.
Hwan Jung LimDepartment of Drug Discovery, Korea Research Institute of Chemical Technology (KRICT) 141 Gajeong-ro, Yuseong-gu Daejeon 34114 Republic of Korea sjunpark@krict.re.kr +82 42 860 7160 +82 42 860 7175.ORCID https://orcid.org/0000-0003-1914-0233
Seong Jun ParkDepartment of Drug Discovery, Korea Research Institute of Chemical Technology (KRICT) 141 Gajeong-ro, Yuseong-gu Daejeon 34114 Republic of Korea sjunpark@krict.re.kr +82 42 860 7160 +82 42 860 7175.ORCID https://orcid.org/0000-0003-1767-0900

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An

Identifiers

PMID41509642
PMCPMC12777572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.